Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 76, Issue 2, Pages 386-391
Publisher
BMJ
Online
2016-06-16
DOI
10.1136/annrheumdis-2016-209285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Melanoma in People with HIV/AIDS in the Pre- and Post-HAART Eras: A Systematic Review and Meta-Analysis of Cohort Studies
- (2014) Catherine M. Olsen et al. PLoS One
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
- (2012) Lene Dreyer et al. ANNALS OF THE RHEUMATIC DISEASES
- The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register
- (2012) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?
- (2012) Friederike Erdmann et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
- (2012) L. K. Mercer et al. RHEUMATOLOGY
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
- (2011) X. Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma
- (2010) Maja A. Hofmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
- (2010) X. Mariette et al. RHEUMATOLOGY
- DANBIO--powerful research database and electronic patient record
- (2010) M. L. Hetland RHEUMATOLOGY
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate
- (2008) Rachelle Buchbinder et al. ARTHRITIS AND RHEUMATISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started